Cell Impact AB (CI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cell Impact AB (CI) has a cash flow conversion efficiency ratio of -0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-19.56 Million ≈ $-2.10 Million USD) by net assets (Skr187.48 Million ≈ $20.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CI equity to assets ratio to measure how much of total assets are equity-financed.
Cell Impact AB - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Cell Impact AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of Cell Impact AB to assess the company's total reinvestment commitment from operating cash flow.
Cell Impact AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cell Impact AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Altiplano Metals Inc
V:APN
|
3.221x |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
-0.358x |
|
Yowie Group Ltd
AU:YOW
|
-0.091x |
|
Clear Blue Technologies International Inc
V:CBLU
|
0.126x |
|
VR Resources Ltd
V:VRR
|
-0.026x |
|
Borqs Technologies Inc.
NASDAQ:BRQSF
|
N/A |
|
The Income & Growth VCT
LSE:IGV
|
-0.017x |
|
Bathurst Metals Corp
V:BMV
|
-0.113x |
Annual Cash Flow Conversion Efficiency for Cell Impact AB (2012–2024)
The table below shows the annual cash flow conversion efficiency of Cell Impact AB from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Cell Impact AB market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr219.08 Million ≈ $23.58 Million |
Skr-62.23 Million ≈ $-6.70 Million |
-0.284x | +14.65% |
| 2023-12-31 | Skr303.37 Million ≈ $32.65 Million |
Skr-100.97 Million ≈ $-10.87 Million |
-0.333x | -1.91% |
| 2022-12-31 | Skr324.35 Million ≈ $34.90 Million |
Skr-105.93 Million ≈ $-11.40 Million |
-0.327x | +45.88% |
| 2021-12-31 | Skr142.62 Million ≈ $15.35 Million |
Skr-86.08 Million ≈ $-9.26 Million |
-0.604x | -156.00% |
| 2020-12-31 | Skr201.89 Million ≈ $21.73 Million |
Skr-47.59 Million ≈ $-5.12 Million |
-0.236x | +74.10% |
| 2019-12-31 | Skr45.05 Million ≈ $4.85 Million |
Skr-41.01 Million ≈ $-4.41 Million |
-0.910x | +59.09% |
| 2018-12-31 | Skr19.14 Million ≈ $2.06 Million |
Skr-42.57 Million ≈ $-4.58 Million |
-2.225x | -224.24% |
| 2017-12-31 | Skr23.09 Million ≈ $2.48 Million |
Skr-15.84 Million ≈ $-1.70 Million |
-0.686x | -218.20% |
| 2016-12-31 | Skr41.38 Million ≈ $4.45 Million |
Skr-8.92 Million ≈ $-960.18K |
-0.216x | +90.92% |
| 2015-12-31 | Skr2.34 Million ≈ $251.78K |
Skr-5.56 Million ≈ $-598.14K |
-2.376x | -233.57% |
| 2014-12-31 | Skr8.22 Million ≈ $884.78K |
Skr-5.86 Million ≈ $-630.13K |
-0.712x | -45.82% |
| 2013-12-31 | Skr16.08 Million ≈ $1.73 Million |
Skr-7.86 Million ≈ $-845.36K |
-0.488x | +89.46% |
| 2012-12-31 | Skr1.68 Million ≈ $181.13K |
Skr-7.80 Million ≈ $-839.57K |
-4.635x | -- |
About Cell Impact AB
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more